Zobrazeno 1 - 10
of 270
pro vyhledávání: '"George T. Grossberg"'
Publikováno v:
Biomarkers in Neuropsychiatry, Vol 9, Iss , Pp 100074- (2023)
Biomarkers in Parkinson’s disease are widely researched in the field of neuropsychiatry. Though Parkinson’s disease is diagnosed clinically, biomarkers prove to be a promising means to identify disease in early stages, track disease progression,
Externí odkaz:
https://doaj.org/article/9c6bcafeb2604c5c8ab45c2d117c288c
Autor:
Martin R. Farlow, Frederick Schmitt, Dag Aarsland, George T. Grossberg, Monique Somogyi, Xiangyi Meng
Publikováno v:
Dementia and Geriatric Cognitive Disorders Extra, Vol 3, Iss 1, Pp 281-290 (2013)
Background: Greater understanding of differences in baseline impairment and disease progression in patients with Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) may improve the interpretation of drug effects and the design of future s
Externí odkaz:
https://doaj.org/article/9643486486f24f43a2876a57c598e7e1
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2010 (2010)
Circadian Rhythm Disturbances (CRDs) affect as many as a quarter of Alzheimer's disease (AD) patients during some stage of their illness. Alterations in the suprachiasmatic nucleus and melatonin secretion are the major factors linked with the cause o
Externí odkaz:
https://doaj.org/article/4689e8aaa7a14d9d8a807bc9cae159d4
Autor:
Aaron S. Kemp, George T. Grossberg, Steven J. Romano, Douglas L. Arnold, J. Michael Ryan, Roger Bullock, David L. Streiner
Publikováno v:
International Journal of Alzheimer's Disease, Vol 2009 (2009)
The International Society for CNS Clinical Trials and Methodology (ISCTM) held its 4th Annual Autumn Conference in Toronto, Ontario, October 6-7, 2008. The purpose of the present report is to provide an overview of one of the sessions at the conferen
Externí odkaz:
https://doaj.org/article/847135aab44c4bfdae3bd64eedf32688
Publikováno v:
Animal Assisted Therapy Use Application by Condition ISBN: 9780323988155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33eb297ce6e556e392e8f96db2dc228f
https://doi.org/10.1016/b978-0-323-98815-5.00006-9
https://doi.org/10.1016/b978-0-323-98815-5.00006-9
Autor:
Sami V. Abate, Eric Altschuler, Kala Chinnaswamy, Dominic M. DeMarco, Simone Swartzentuber Emmons, Chalotte Glintborg, George T. Grossberg, Carin M. Lefkowitz, Beth L. Macauley, Jessica Nelson, Greg Para, null Paws for Heroes Client - Army Veteran, Diane Scotland-Coogan, James Whitworth
Publikováno v:
Animal Assisted Therapy Use Application by Condition ISBN: 9780323988155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14f6e30d05db6b14ad503ea0e90d67e3
https://doi.org/10.1016/b978-0-323-98815-5.01002-8
https://doi.org/10.1016/b978-0-323-98815-5.01002-8
Publikováno v:
Clinics in Geriatric Medicine. 38:99-118
Over-the-counter (OTC) products such as pharmaceuticals, dietary supplements, vitamins, and herbal remedies are widely available and copiously used by older adults for health maintenance and symptom management. Owing to physiology, multimorbidity, an
Autor:
George T Grossberg, Daniel Lee, Mary Slomkowski, Nanco Hefting, Dalei Chen, Klaus Groes Larsen, Eva Kohegyi, Mary Hobart, Jeffrey L Cummings
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Mikhail Davidson, Howard Fillit, Martin Cloutier, George T. Grossberg, Patrick Gagnon-Sanschagrin, Christy R. Houle, Ross A. Baker, Elizabeth Serra, Annie Guerin, Myrlene Sanon Aigbogun
Publikováno v:
International Journal of Geriatric Psychiatry. 36:1959-1969
Objectives To describe characteristics and compare clinical outcomes including falls, fractures, infections, and neuropsychiatric symptoms (NPS) among long-term care residents with dementia with and without agitation. Methods A cross-sectional second
Publikováno v:
Expert opinion on pharmacotherapy. 23(11)
Alzheimer's disease (AD) is a debilitating disease, with no cure. Recently, a monoclonal antibody (aducanumab) directed toward amyloid aggregates was approved as a disease-modifying treatment (DMT) for the disease. Other compounds (symptomatic or DMT